AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Bottom 4%
#4395 out of 4559 analysts
Average Return
-13.76%
Win Rate
35%20 out of 57
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oyster Point Pharma IncOYST | +149.89% | $4.47 | $11.17 | 2022-07-17 - 2023-01-03 | Buy |
Iveric Bio IncISEE | +80.13% | $20.94 | $37.72 | 2022-11-03 - 2023-05-02 | Buy |
Iveric Bio IncISEE | +71.85% | $21.95 | $37.72 | 2023-02-16 - 2023-05-02 | Buy |
4d Molecular Therapeutics IncFDMT | +71.62% | $18.36 | $31.51 | 2023-03-15 - 2024-03-15 | Buy |
Iveric Bio IncISEE | +59.36% | $23.67 | $37.72 | 2023-03-01 - 2023-05-02 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aldeyra Therapeutics IncALDX | 7 | Buy | $10.00 | +154.45% | Reinstates | 22 days ago |
Lyra Therapeutics IncLYRA | 3 | Buy | $12.00 | +130.33% | Reiterates | a month ago |
Hillevax IncHLVX | 2 | Buy | $28.00 | +115.72% | Reiterates | a month ago |
Eyenovia IncEYEN | 9 | Buy | $12.00 | +2,225.58% | Reiterates | a month ago |
Optinose IncOPTN | 2 | Buy | $5.00 | +385.44% | Reiterates | a month ago |
Ocuphire Pharma IncOCUP | 7 | Buy | $20.00 | +1,224.50% | Reiterates | a month ago |
Phathom Pharmaceuticals IncPHAT | 3 | Buy | $28.00 | +210.77% | Reiterates | 2 months ago |
4d Molecular Therapeutics IncFDMT | 10 | Buy | $36.00 | +36.42% | Reiterates | 2 months ago |
Unity Biotechnology IncUBX | 4 | Buy | $10.00 | +575.68% | Reiterates | 5 months ago |
FabrinetFN | 1 | Buy | $28.00 | -82.94% | Reiterates | 8 months ago |
Opthea LtdOPT | 3 | Buy | $14.00 | +314.20% | Reiterates | 9 months ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | +0.13% | Downgrades | a year ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.